United States News All stories

Talawar Therapeutics and JATT II (NASDAQ:JATT) have entered into a definitive business combination agreement to create a Nasdaq-listed biotechnology company expected to trade as TLWR in the second half of 2026.

FTAI Infrastructure (NASDAQ:FIP) announced the completion of its acquisition of Tidewater Logistics, a barge and rail transloading company operating in Ohio, West Virginia, and Texas.

Diana Shipping (NYSE:DSX) extended its tender offer for all outstanding shares of Genco Shipping & Trading (NYSE:GNK) it does not already own to July 10, 2026 at 5:00 p.m. ET.

Larimar Therapeutics (NASDAQ:LRMR) announced the submission of the first module of a rolling Biologics License Application to the U.S. Food and Drug Administration seeking accelerated approval of nomlabofusp for the treatment of Friedreich’s ataxia.

Honeywell Technologies (NASDAQ:HON) completed the spin-off of its Aerospace Technologies business, which is now trading independently as Honeywell Aerospace (NASDAQ:HONA).

United Therapeutics (NASDAQ:UTHR) announced that the U.S. Food and Drug Administration has granted premarket approval of the LungFX device for use in centralized ex vivo lung perfusion.

Vertical Aerospace (NYSE:EVTL) announced a long-term agreement with Astronics Corporation (NASDAQ:ATRO) to supply the low-voltage power distribution system for its Valo electric vertical take-off and landing aircraft.

Constellium (NYSE:CSTM) announced the sale of its ownership stake in an automotive structures joint venture in Changchun, China, to a Chinese automotive holding company.

Korn Ferry (NYSE:KFY) has entered into a definitive agreement to acquire UK-headquartered AMS, creating a global leader in talent and organizational consulting.

Zymeworks has agreed to acquire Theravance Biopharma (NASDAQ:TBPH) for $17 per share in cash.

Kandi Technologies (NASDAQ:KNDI) has agreed to acquire a 51% controlling stake in Hangzhou Xinchu New Energy for RMB20 million, approximately US$2.9 million, in cash.

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) announced that Enhertu (trastuzumab deruxtecan) has been approved in the European Union as monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (IHC 3+) solid tumors who have received prior treatment and who have no satisfactory alternative treatment options.

AbbVie (NYSE:ABBV) said the CHMP has issued a positive opinion recommending approval of upadacitinib (RINVOQ) 15 mg and 30 mg once daily for adults and adolescents with severe alopecia areata in the EU.

Waymo, owned by Alphabet (NASDAQ:GOOGL), has ended its Phoenix robotaxi availability on Uber Technologies (NYSE:UBER), closing a pilot that delivered hundreds of thousands of autonomous trips.

BCAL Diagnostics (ASX:BDX), an Australian healthcare company focused on early cancer detection, has secured firm commitments for a further A$4.9 million under its existing A$10 million convertible note facility, with the additional funds to be drawn down as required.

CMB.TECH (NYSE:CMBT) announced the sale of two 2023-built Suezmax tankers, Brest and Brugge, each with a deadweight tonnage of 156,851.

NeuroSense Therapeutics (NASDAQ:NRSN) reported that its Phase 2b PARADIGM study of PrimeC in amyotrophic lateral sclerosis met its primary endpoint, showing a statistically significant reduction in neuron-derived TDP-43 compared with placebo at Day 180.

Replimune (NASDAQ:REPL) reported fiscal 2026 results with a net loss of $313.9 million, research and development expenses of $221.2 million, and selling, general and administrative expenses of $98.7 million.

The Albanese Government plans to strengthen Australia’s social media minimum age law by giving the eSafety Commissioner broader information‑gathering powers and doubling the maximum penalty for systematic breaches from $49.5 million to $99 million.

Hawk Resources (ASX:HWK) has reported new lab assays from hole DD26CT004 at its Cactus copper‑gold project in Utah, intersecting 72.9m at 0.36% copper and 2.0ppm silver from 18m below surface and confirming more near surface copper, silver and molybdenum in the Cactus Corridor.

• BlackBerry reported Q1 FY2027 revenue of $152.9 million, up 26% year over year, with adjusted EBITDA of $36.3 million and GAAP operating income of $15.3 million.
• The comparison group shows a wide revenue gap, from Cerence’s $64.2 million quarterly revenue to Palo Alto Networks’ $3 billion quarterly revenue.
• The main sector test is whether AI security, connected-vehicle software, and government communications can keep growing while margins stay under control.

• Micron Technology reported $41.46 billion in quarterly revenue as the firm capitalized on surging data center component demand.
• The semiconductor manufacturer recorded a GAAP net income of $28.24 billion and declared a quarterly dividend of $0.15 per share.
• Global hardware manufacturers must carefully secure raw materials to execute aggressive revenue projections amid volatile enterprise capital expenditures.

• FedEx reported $25 billion in fourth-quarter fiscal 2026 revenue while executing a spin-off of its freight division to consolidate core operations.
• The logistics provider exceeded cost-cutting targets by securing over $1 billion in structural savings and achieving an adjusted earnings per share of $6.60.
• Global transportation firms face mounting pressure to offset mixed profitability trends by heavily reducing capital spending and divesting secondary business units.

• AbbVie agreed to acquire Apogee Therapeutics in a $10.9 billion all-cash transaction, paying a 60% premium to secure a late-stage immunology pipeline.
• The company will pay $135.11 per share, with executives projecting the deal will not become accretive to adjusted earnings until 2032.
• Large pharmaceutical manufacturers face intense capital pressure to acquire unproven, long-acting biologics to offset impending revenue losses from patent expirations.